Rohann Correa
@DrCorreaRO
Followers
551
Following
613
Media
8
Statuses
168
Radiation Oncologist at London Health Sciences Centre & Assistant Professor, Western University, London, Ontario
Canada
Joined November 2018
https://t.co/zNSBD5YVvV A recent analysis from IROCK in press. This time looking at outcomes for clear vs non-clear cell RCCs @_ShankarSiva @PeterMacRadOnc @DrCorreaRO @NicholasZaorsky
2
10
23
@SimonLo21054188 @LPonsky @drviviantan @_ShankarSiva @DrAlexLouie @NicholasZaorsky @spsutkaMD @DrCorreaRO @ChadTangMD @Raquib_Hannan @MichaelStaehler @AMuacevic @VedangMurthy IROCK has certainly made great progress! This map always feels out of date as we seem to activate a site each week but it show the expansion over the last few years.
1
5
13
"Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom ➡️SABR to median=16 "poly"metastases in patients who had already exhausted multiple lines of systemic therapy ➡️4x dose levels (up to 6Gyx5). ➡️No safety signals, QoL maintained. https://t.co/ZIjhtg6RCJ Congrats! 👏👏
4
78
195
Congratulations Nick!
Protecting kidney function after local renal cell carcinoma therapy Interview @UrologyTimes #ASTRO24 @ASTRO_org
https://t.co/0NdzSuWyj9
@crajoulh @_ShankarSiva @mwang_cwru @DrAlexLouie @ASwaminathMD @EricLehrer @angela_jia_ @DrCorreaRO @SimonLo21054188 @DrSpratticus @LPonsky
0
0
5
Couldn't agree more! I learned so much from these excellent panelists!
What a fantastic session ! Could not have asked for better speakers and incredible discussion !
0
0
5
Thank you Dr. @LauraBukavinaMD & @DrVitagliano for running this excellent, multi-disciplinary session! Glad to share evidence generated by @_ShankarSiva @Raquib_Hannan @DrAlexLouie @NicholasZaorsky @SimonLo21054188 & many other colleagues! #IROCK
@DrCorreaRO reviews the indications and outcomes of SBRT in T1 tumors, highlighting the evolving perspectives on radiation therapy and its results. We are all excited to see more in the near future @SIU_urology #SIU2024NewDelhi
1
5
20
@DrCorreaRO reviews the indications and outcomes of SBRT in T1 tumors, highlighting the evolving perspectives on radiation therapy and its results. We are all excited to see more in the near future @SIU_urology #SIU2024NewDelhi
0
6
17
@ASTRO_org 2024 will mark the 10th Anniversary for IROCK with hopefully decades to come! @_ShankarSiva @DrAlexLouie @MellyB_7 @DrCorreaRO @NicholasZaorsky
9
2
20
Stereotactic Body Radiotherapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide - ScienceDirect
1
6
19
The @OncoAlert 🚨Newsletter NOW OUT Covering July 5-11. 2024 REGISTER at https://t.co/lhZHAIVI0c or https://t.co/dq8GEzl9ps Discussing: ✅UNICANCER-PRODIGE23🧪 in #RectalCancer ✅Renal function after SABR in 1ry #KidneyCancer
@drviviantan @DrAlexLouie
@DrCorreaRO
0
17
31
🔥Hot off the press @EurUrolOncol IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc
https://t.co/hogLg40zkk Thankful for mentors @_ShankarSiva
@DrAlexLouie @DrCorreaRO
3
53
131
Congratulations to fellow presenters @MdStephans @Rrkotecha for such excellent talks & to the #ISRSUSA2024 @ISRSy attendees for super-insightful questions!
Star studded group reviewing SBRT for oligometastatic disease. @DrCorreaRO @MdStephans @Rrkotecha speaking and Dr. Amol Ghia and @MichaelTMilano moderating. #SBRT being discussed at @ISRSy #ISRSUSA2024 Congress
0
0
9
🙏🏽🙏🏽 @bslotman Great to see you again and I was proud to give a well-deserved nod of appreciation to immune analysis expert Dr. @SchneidersFamke & @amsterdamumc - collaborative studies are ongoing!
1
0
16
0
1
8
Good catch-up and moderating @ISRSy #ISRSUSA2024 GU prostate SABR session with @DrCorreaRO, co-fellows @Sunnybrook @UofTDRO @DrAndrewLoblaw
Excellent GU abstracts presented @ISRSy #ISRSUSA2024 Congress. #SBRT @DrCorreaRO and @weeloonong moderating.
1
4
31
This novel study with @DropletBiosci is open & accruing steadily thanks to 💪🏽💪🏽 collaboration with colleagues @WesternOtoHNS! Not possible without mentors/collaborators @drdavidpalma @nicholslab1 @jpzevallos @aadel_chaudhuri & many others 🙏🏽🙏🏽
Thrilled to be working with @DropletBiosci and @DrCorreaRO head and neck cancer research projects!! @WesternOtoHNS @SchulichMedDent
1
2
13
Now online @IJROBP Early results of the randomized Hope trial. Is ultra-HypoRT to the pelvis post prostate BT as well tolerated as conventional RT? https://t.co/PKz3TmcbVT
@agomeziturriaga @kevinmartell @DrStanLiu
5
11
37
Congrats @aadel_chaudhuri on this exciting work, was my pleasure to discuss at #ASTRO23. Look forward to continuing our chat on where we go from here! @drdavidpalma
Beautiful piece on our @Nature_NPJ Precision Oncology article in @Medscape: "We have exciting real-world data that ctDNA detection and levels can risk-stratify oligometastatic NSCLC" Thx to discussant @DrCorreaRO! @semenko @BrunaPellini @susannagreer
https://t.co/2UEaS9GA7j
1
2
11
@jryckman3 Hi Jeff, we recently wrote and editorial on this @DrCorreaRO - our take here; https://t.co/GmCjsFxt6n
3
2
20
@DrCorreaRO gives a ‘tour de force’ overview of the history of #radiotherapy for #kidneycancer. The evidence is building considerably over time. Hilarious opening slide shouting out the IROCK consortium. Looking forward to IROCK launch in 2 hours! https://t.co/p4enSmsZxk
#kcsm
0
12
45